Navigation Links
Roche/Chugai's Bitopertin Will Garner Nearly $1.5 Billion in Major-Market Sales in 2022 as the First Approved Treatment for Negative Symptoms in Schizophrenia
Date:8/22/2013

s is a Decision Resources Group company.

About Decision Resources Group

Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Survey Reveals How Patients Choose Their Pharmacy; AccentHealth Garners Consumer Insights from the Waiting Room
2. Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering
3. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
4. Cardinal Health Supports Future Pharmacists With Nearly $1 Million In Scholarships
5. Zarbees Partners with K.I.D.S. by Donating Nearly 23,000 Bottles of All-Natural Cough Syrup to Underserved Families Across the Globe
6. ViiV Healthcare commits nearly £4M in Positive Action for Children Fund grants for programmes focused on alleviating burden of HIV on women and children
7. Global Market for Disposable Medical Supplies To Reach Nearly $200 Billion in 2016
8. Nearly Half of Children Under 2 Years of Age Receive Some Vaccinations Late
9. Surveyed U.S. Pulmonologists Expect to Treat Nearly 50 Percent of Their Severe, Refractory Asthma Patients With a Biologic or Biosimilar Version of Xolair By the End of 2018
10. Nearly 8 Million Healthcare Personnel Come in Contact with Chemotherapy Drugs, According to CDC
11. Nearly 30 Percent of Women Fail to Pick Up New Prescriptions for Osteoporosis, Kaiser Permanente Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)...  In recognition of the increased risks that ... flu, pneumonia, shingles and other illnesses, CVS/pharmacy ® ... to be Senior Vaccination Month. Because people,s immune ... that adults ages 65 years and older stay ... and MinuteClinic nurse practitioners and physician assistants will ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire/ ... market research report is available in ... Therapeutics in Asia-Pacific Markets to 2020 ... Unmet Need in Newly Diagnosed and ... http://www.reportlinker.com/p02343492/Glioblastoma-Multiforme-Therapeutics-in-Asia-Pacific-Markets-to-2020---Novel-Therapeutic-Approaches-Target-High-Unmet-Need-in-Newly-Diagnosed-and-Recurrent-GBM.html Glioblastoma ...
(Date:8/28/2014)... , Aug. 28, 2014 Telik, Inc. (OTCQB: ... that merged with MabVax Therapeutics, Inc. on July ... progress related to the development of its lead ... recovered using the Company,s internally developed antibody discovery ... for multiple antibody based therapeutic and diagnostic products ...
Breaking Medicine Technology:September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 2Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 3Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 5Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 6Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 7Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 8Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 9Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 2Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 4
... report is available in its catalogue: , , , ... , , http://www.reportlinker.com/p0191978/China-Patient-Monitoring-Market-Outlook-to-2016.html ... China Patient Monitoring Market Outlook to 2016 , , , ... , , "China Patient Monitoring Market Outlook ...
... June 1 Clinicians at Institut Catala d,Oncologia (ICO) in ... using RapidArc® radiotherapy from Varian Medical Systems (NYSE: VAR). A 73-year-old prostate ... the country to receive the fast and efficient treatment. , ... "The treatment went very well and the ...
Cached Medicine Technology:Reportlinker Adds China Patient Monitoring Market Outlook to 2016 2Reportlinker Adds China Patient Monitoring Market Outlook to 2016 3Reportlinker Adds China Patient Monitoring Market Outlook to 2016 4Reportlinker Adds China Patient Monitoring Market Outlook to 2016 5Reportlinker Adds China Patient Monitoring Market Outlook to 2016 6Reportlinker Adds China Patient Monitoring Market Outlook to 2016 7Reportlinker Adds China Patient Monitoring Market Outlook to 2016 8Reportlinker Adds China Patient Monitoring Market Outlook to 2016 9Reportlinker Adds China Patient Monitoring Market Outlook to 2016 10Reportlinker Adds China Patient Monitoring Market Outlook to 2016 11Reportlinker Adds China Patient Monitoring Market Outlook to 2016 12Reportlinker Adds China Patient Monitoring Market Outlook to 2016 13Reportlinker Adds China Patient Monitoring Market Outlook to 2016 14Reportlinker Adds China Patient Monitoring Market Outlook to 2016 15Reportlinker Adds China Patient Monitoring Market Outlook to 2016 16Reportlinker Adds China Patient Monitoring Market Outlook to 2016 17Reportlinker Adds China Patient Monitoring Market Outlook to 2016 18Reportlinker Adds China Patient Monitoring Market Outlook to 2016 19Reportlinker Adds China Patient Monitoring Market Outlook to 2016 20Reportlinker Adds China Patient Monitoring Market Outlook to 2016 21Reportlinker Adds China Patient Monitoring Market Outlook to 2016 22Reportlinker Adds China Patient Monitoring Market Outlook to 2016 23Reportlinker Adds China Patient Monitoring Market Outlook to 2016 24Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian 2Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian 3Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian 4
(Date:8/28/2014)... (PRWEB) August 28, 2014 Millennium Treatment Group ... America is extremely large, and Millennium Treatment Group is working ... treatment that they need. , According to the National ... than 21 million Americans could have benefited from treatment for ... people received help. This means that there is a large ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 American adults ... industry on the Internet will now have a simpler ... company. In one click this year, some of the ... http://quotespros.com/life-insurance.html . , The promoted plans that ... Pros finder tool represent popular policies. The term, guaranteed ...
(Date:8/28/2014)... plans its exit strategy from the war, now may be ... health care to veterans, says a Perspective piece in the ... go on doing more of the same is to fail ... and population structure pose in the longer run," said William ... Practice, and David Auerbach, from the RAND Corporation, in the ...
(Date:8/28/2014)... Greenwich, CT and Ann Arbor, MI (PRWEB) August 28, ... I portfolio company and the nation’s leading intraoperative neurophysiology ... Gecsey, President and CFO, to the position of Chief ... 2010 as CFO, was promoted to President and CFO ... Biotronic’s continued growth and success. , “Bill’s efforts ...
(Date:8/28/2014)... August 28, 2014 Kirklyn Smith, an office ... may be a new world’s record by walking 5,000 miles ... we are constantly amazed by the thousands of individual stories ... just seem to stand out more than the others. , ... hour step count which tallies a range of 54,823 steps ...
Breaking Medicine News(10 mins):Health News:Millennium Treatment Group Works to Close Treatment Gap 2Health News:Best Life Insurance Rates for 2014 Now Promoted at Insurer Website 2Health News:A VA exit strategy 2Health News:Biotronic NeuroNetwork Announces the Promotion of Bill Gecsey to CEO 2Health News:There are many reasons why Americans' exercise levels have declined - Meet an executive that refuses to sit still with his TrekDesk Treadmill Desk even in a sedentary job 2
... in which health care providers are rewarded with more ... in the UK and Australia. The approach has ... Medicare and Medicaid Services (CMS), which is responsible for ... the US is slated for 2013, when hospitals will ...
... strategy for women who can potentially benefit from repeat mammography ... single intervention that is best, according to a study published ... Cancer Institute. Regular mammography screening has been ... ages of 50 and 74 by approximately 23%. However, until ...
... from the Action to Control Cardiovascular Risk in Diabetes ... kind to determine whether intensive blood glucose (sugar) control ... results show that the benefits of intensive therapy need ... cardiovascular disease-related death, increased weight gain, and high risk ...
... ... winning products were celebrated in a ceremony marked by an announcement of the competition,s gold ... the category of general hospital devices and therapeutic products. , ... Gainesville, FL (Vocus) June 29, 2010 -- Earlier this year, ...
... ... Web site for parents, has launched KidsDoc Symptom Checker, a new online tool to help ... , ... 29, 2010 -- What should you do if your child develops a fever, cough, vomiting, ...
... insurance, low-income women had lower rates of mammography screening ... likelihood of screening. "Health insurance is a ... a sufficient condition," said Nasar Ahmed, Ph.D., chair of ... Public Health and Social Work at Florida International University. ...
Cached Medicine News:Health News:Pay-for-performance for hospitals 2Health News:Interventions to promote repeat breast cancer screening with mammography 2Health News:Intensively lowering glucose: Possible benefits must be weighed against risks 2Health News:Intensively lowering glucose: Possible benefits must be weighed against risks 3Health News:Xhale Innovation's HyGreen Hand Hygiene System Brings Home the Gold 2Health News:AAP Offers New Online Pediatric Symptom Checker on HealthyChildren.org 2Health News:Counseling increased mammography use among low-income women with health insurance 2
Escherichia coli - For the qualitative detection of Escherichia coli 0157 and 0157:H7 in food products. Accessories BinaxNOW EH E.coli 0157 & 0157:H7 Control Swab Pack (510-000), BinaxNow E.coli...
... For the qualitative differential ... (P.f) antigen and an antigen ... four species of malaria:plasmodium falciparum ... ovale (P.o) and Plasmodium malariae ...
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
Medicine Products: